Invesco Pharmaceuticals ETF (NYSEARCA:PJP – Get Free Report) shares reached a new 52-week high on Friday. The stock traded as high as $131.88 and last traded at $131.0650, with a volume of 2,989 shares trading hands. The stock had previously closed at $128.88.
Invesco Pharmaceuticals ETF Stock Performance
The business’s fifty day moving average is $125.76 and its two-hundred day moving average is $114.33. The company has a market cap of $582.16 million, a P/E ratio of 15.59 and a beta of 0.44.
Hedge Funds Weigh In On Invesco Pharmaceuticals ETF
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Lodestone Wealth Management LLC acquired a new position in Invesco Pharmaceuticals ETF during the 3rd quarter worth $25,000. Latitude Advisors LLC acquired a new position in Invesco Pharmaceuticals ETF in the third quarter valued at $29,000. Fifth Third Bancorp purchased a new stake in shares of Invesco Pharmaceuticals ETF during the first quarter worth approximately $36,000. Global Assets Advisory LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF in the first quarter valued at about $42,000. Finally, Integrated Wealth Concepts LLC purchased a new position in shares of Invesco Pharmaceuticals ETF during the 2nd quarter worth approximately $55,000.
About Invesco Pharmaceuticals ETF
PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.
Further Reading
- Five stocks we like better than Invesco Pharmaceuticals ETF
- Microsoft Earnings Expose a Growing Divide in the Magnificent 7 AI Trade
- Silicon Shock: Intel’s 25% Valuation Reset
- Advanced Micro Devices’ Meta Platforms Partnership Goes Beyond a $1 Billion Investment
- Chipotle’s $32 Floor: Is a Major Stock Rebound Coming?
Receive News & Ratings for Invesco Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
